Phathom Pharmaceuticals Files 8-K on Security Holder Vote
Ticker: PHAT · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1783183
| Field | Detail |
|---|---|
| Company | Phathom Pharmaceuticals, Inc. (PHAT) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Phathom Pharma had a shareholder vote on June 3rd, details to follow.
AI Summary
Phathom Pharmaceuticals, Inc. filed an 8-K on June 9, 2025, reporting on a matter submitted to a vote of its security holders on June 3, 2025. The filing does not disclose the specific details of the vote or the outcome.
Why It Matters
This filing indicates a significant corporate action or decision was put to a vote by Phathom Pharmaceuticals' shareholders, which could impact the company's future direction or governance.
Risk Assessment
Risk Level: medium — The filing is a procedural update regarding a shareholder vote, but the lack of detail on the vote's subject and outcome introduces uncertainty.
Key Players & Entities
- Phathom Pharmaceuticals, Inc. (company) — Registrant
- June 3, 2025 (date) — Date of earliest event reported
- June 9, 2025 (date) — Date of report
FAQ
What specific matter was submitted to a vote of Phathom Pharmaceuticals' security holders on June 3, 2025?
The filing does not specify the exact matter that was submitted for a vote.
What was the outcome of the vote by Phathom Pharmaceuticals' security holders on June 3, 2025?
The filing does not disclose the results or outcome of the shareholder vote.
Is this 8-K filing related to a specific corporate event or transaction?
The filing indicates a 'Submission of Matters to a Vote of Security Holders' but does not detail the event.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 3, 2025.
What is the principal executive office address for Phathom Pharmaceuticals, Inc.?
The principal executive offices are located at 100 Campus Drive, Suite 102, Florham Park, New Jersey 07932.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding Phathom Pharmaceuticals, Inc. (PHAT).